JCR Pharmaceuticals Co (TSE:4552) 3-Year Revenue Growth Rate : 12.10% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co 3-Year Revenue Growth Rate?

JCR Pharmaceuticals Co's Revenue per Share for the three months ended in Dec. 2023 was 円75.36.

During the past 12 months, JCR Pharmaceuticals Co's average Revenue per Share Growth Rate was 24.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 13.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of JCR Pharmaceuticals Co was 30.10% per year. The lowest was -4.20% per year. And the median was 7.70% per year.

Competitive Comparison of JCR Pharmaceuticals Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JCR Pharmaceuticals Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's 3-Year Revenue Growth Rate falls into.

JCR Pharmaceuticals Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

JCR Pharmaceuticals Co (TSE:4552) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

JCR Pharmaceuticals Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of JCR Pharmaceuticals Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

JCR Pharmaceuticals Co (TSE:4552) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

JCRRF:USA

Address

3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021

Website

http://www.jcrpharm.co.jp

JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co (TSE:4552) Headlines

No Headlines